Clinical factors | TCGA-BLCA n = 403% | GSE32894 n = 224% | ||
---|---|---|---|---|
Age | ||||
> 60 | 296 | 73.45 | 178 | 79.46 |
≤ 60 | 107 | 26.55 | 46 | 20.54 |
Gender | ||||
Male | 298 | 73,95 | 163 | 72.77 |
Female | 105 | 26.05 | 61 | 27.23 |
Pathological stage | ||||
Stage I&II | 130 | 32.26 | - | - |
Stage III | 140 | 34.74 | - | - |
Stage IV | 131 | 32.51 | - | - |
unknown | 2 | 0.49 | - | - |
T stage | ||||
≤ T2 | 121 | 30.02 | 216 | 96.43 |
T3 | 191 | 47.39 | 7 | 1.74 |
T4 | 57 | 14.14 | 1 | 0.25 |
unknown | 34 | 8.44 | - | - |
Lymphatic node metastasis | ||||
Negative | 235 | 58.31 | - | - |
Positive | 125 | 31.02 | - | - |
Unknown | 43 | 10.67 | - | - |
Angiolymphatic Invasion | ||||
Negative | 127 | 31.52 | - | - |
Positive | 148 | 36.72 | - | - |
unknown | 128 | 31.76 | - | - |
Histological grade | ||||
High | 380 | 94.53 | - | - |
Low | 20 | 4.98 | - | - |
Vital status | ||||
Alive | 225 | 55.83 | 199 | 88.84 |
Dead | 178 | 45.17 | 25 | 11.16 |
Grade (WHO1999) | ||||
G1 | - | - | 45 | 20.09 |
G2 | - | - | 84 | 37.50 |
G3 | - | - | 93 | 41.52 |